Related Experiment Video

Updated: May 16, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

The Many Faces of MDM2 Binding Partners

Maurisa F Riley1, Guillermina Lozano

  • 1Department of Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Genes & Cancer
|November 15, 2012
PubMed

Insights

The Mdm2 protein regulates the p53 tumor suppressor. Dysregulation of Mdm2 impacts cell death, potentially leading to cancer due to errors in its complex regulatory mechanisms.

Area of Science:

  • Molecular biology
  • Cancer biology
  • Cellular regulation

Background:

  • Mdm2 is a key regulator of the p53 tumor suppressor protein.
  • Mdm2 activity is controlled by multiple regulatory mechanisms, including transcriptional, post-transcriptional, and post-translational modifications.
  • Aberrant Mdm2 regulation is implicated in tumor development and the failure of programmed cell death.

Purpose of the Study:

  • To review the multifaceted roles of Mdm2 in regulating p53.
  • To highlight the implications of Mdm2 dysregulation in cancer.
  • To discuss the p53-independent functions of Mdm2.

Main Methods:

  • Literature review of Mdm2 and p53 interactions.
  • Analysis of regulatory mechanisms controlling Mdm2 expression and activity.
  • Examination of Mdm2's role in genome stability and cancer.

Main Results:

  • Mdm2 controls p53 activity in normal and stressed cells through intricate regulatory pathways.
  • Errors in Mdm2 regulation, such as locus amplification, lead to tumor phenotypes.
  • Mdm2 possesses functions beyond p53 regulation, impacting genome stability.

Conclusions:

  • Mdm2's complex regulatory network is crucial for maintaining cellular homeostasis and preventing cancer.
  • Understanding Mdm2's diverse functions, including its E3-ligase and p53-independent activities, is vital for cancer research.
  • Targeting Mdm2 regulatory pathways offers potential therapeutic strategies for cancer treatment.
Keywords:
DNA damageMdm2p53tumorigenesisubiquitination

More Related Videos

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...